{
    "nct_id": "NCT05535738",
    "official_title": "Biologics and Blistering - Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Through Suction Blistering",
    "inclusion_criteria": "* Healthy adult subjects over the age of 18 years with no skin diseases\n* Patients with dermatologic conditions such as atopic dermatitis, history of localized non-melanoma, keratinocytic skin cancer\n* Patients with previous clinical patch testing\n* UMass Medical School students and employees are eligible to participate.\n* Non-English-speaking individuals are also eligible with the assistance of an interpreter and an approved short form consent in the appropriate language.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Adults unable to give consent\n* History of the following specific dermatologic conditions (which would be confounders due to their particular immunologic etiologies, specifically the TNFa and IL-17 pathways which oppose the Th2 pathway): pityriasis rubra pilaris and psoriasis\n* Patients actively receiving whole body phototherapy\n* Patients actively receiving systemic broad-spectrum immunosuppression (prednisone, mycophenolate mofetil, azathioprine, methotrexate)\n* Any history of poor wound healing\n* History of uncontrolled diabetes\n* History of easily torn skin\n* Any known cardiac arrhythmia or history of heart failure\n* History of demyelinating disease\n* History of liver disease or alcohol abuse\n* History of melanoma\n* Pregnant women\n* Individuals who are high risk for tuberculosis including prisoners, immigrants from TB- endemic areas, or US-based travelers who have visited TB-endemic areas\n* Individuals with a self-reported personal history of infection with latent or active tuberculosis, HIV, Hepatitis B, or Hepatitis C will not be included, because the type of immunotherapies that will be used in this study may interfere with these conditions.\n* For similar reasons, we will not be including individuals with signs of current or active infection, self-reported personal history of recurrent infections, or conditions that compromise the immune system, such as patients with malignancy (except non- melanoma, keratinocytic skin cancers).",
    "miscellaneous_criteria": ""
}